Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GeneTex
Irvine, California, United Statesgenetex.com ↗
- Ownership
- Private
- Employees
- ~150
- Development stage
- Commercial
01
Overview
GeneTex provides rigorously validated antibodies and related reagents supporting biomedical discovery. Their products are widely cited in academic literature. They emphasize stringent quality control with ISO certifications and advanced validation protocols but do not have clinical trial results as they do not develop drugs or therapies.
- Therapeutic areas
- OncologyMetabolic DisordersImmunologyNeurologyInfectious Diseases
- Modalities
- Polyclonal antibodyMonoclonal antibodyRecombinant monoclonal antibodyRecombinant protein
- Industry
- Chemicals & Materials
Beyond the preview
Go deeper on GeneTex.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GeneTex.